The deal builds on an existing research collaboration between Eli Lilly and Alchemab to discover new ALS drugs.

No matter how high President Trump cranks up tariffs, many industries are never coming back to the U.S. For industries that ...

Shanghai-based medical device start-up United InnoMed plans to collaborate with medical institutions in Hong Kong on clinical ...

In 2024, the European Medicines Agency (EMA) approved lecanemab for the treatment of early Alzheimer's disease in patients without contraindications or risk factors for side-effects. This approval ...

HiveMQ, the global leader in IoT data streaming, today announced it has partnered with Snowflake to support the acceleration of the AI Data Cloud for Manufacturing through a new automotive-specific ...

The $560 million company will sack staff and stop selling products at Woolworths and Priceline and concentrate on selling ...

Gov. Mike Braun, as expected, signed a bill Thursday requiring the Indiana Economic Development Corp. to be more transparent ...

Wobble Genomics, a biotechnology company working to improve outcomes in cancer through better diagnosis and therapy selection, via a novel ultra-sensitive ...

Eli Lilly’s expanding US production and advancing pipeline offset near-term headwinds and support bullish conviction. Read ...

Eli Lilly on Thursday downplayed CVS Health's decision to drop the company's obesity drug Zepbound from some lists of ...